NAGE
Niagen Bioscience, Inc. Common Stock
NAGE
NAGE
58 hedge funds and large institutions have $27.7M invested in Niagen Bioscience, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+5
Holders Change %
+9.43%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
13
Reduced
9
Closed
13
Calls
$452K
Puts
$67K
Net Calls
+$385K
Net Calls Change
-$6.45M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$978K |
| 2 |
Goldman Sachs
New York
|
+$901K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$812K |
| 4 |
Invesco
Atlanta,
Georgia
|
+$723K |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$523K |
Top Sellers
| 1 |
PM
Precept Management
Dallas,
Texas
|
-$1.18M |
| 2 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$676K |
| 3 |
Renaissance Technologies
New York
|
-$265K |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$257K |
| 5 |
JPMorgan Chase & Co
New York
|
-$236K |
